Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Single-cell transcriptome profiling of tumour tissue isolates allows the characterization of heterogeneous tumour cells along with neighbouring stromal and immune cells. Here we adopt this powerful approach to breast cancer and analyse 515 cells from 11 patients. Inferred copy number variations from the single-cell RNA-seq data separate carcinoma cells from non-cancer cells. At a single-cell resolution, carcinoma cells display common signatures within the tumour as well as intratumoral heterogeneity regarding breast cancer subtype and crucial cancer-related pathways. Most of the non-cancer cells are immune cells, with three distinct clusters of T lymphocytes, B lymphocytes and macrophages. T lymphocytes and macrophages both display immunosuppressive characteristics: T cells with a regulatory or an exhausted phenotype and macrophages with an M2 phenotype. These results illustrate that the breast cancer transcriptome has a wide range of intratumoral heterogeneity, which is shaped by the tumour cells and immune cells in the surrounding microenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Limited T-cell recruitment and function in the TME correlates with poor prognosis in BC (21,22).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709 · cited 1×
“4.0b (default parameters) 55 , and relative gene expression was quantified as transcript per million (TPM) using RSEM v1.”
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179
GSVA: gene set variation analysis for microarray and RNA-Seq data
Hänzelmann, S., Castelo, R., & Guinney, J. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-7 · Cited by 15,440 · cited 1×
“To assess gene expression signatures and pathway activation, a non-parametric and unsupervised software algorithm called GSVA software in the R package 58 with the RNA-seq mode was used.”
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R., Garimella, K. V., Maguire, J. R., Hartl, C., Philippakis, A. A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,456
Inferring tumour purity and stromal and immune cell admixture from expression data
Yoshihara, K., Shahmoradgoli, M., Martínez, E., Vegesna, R., Kim, H., Torres-Garcia, W., Treviño, V., Shen, H., Laird, P. W., Levine, D. A., et al. (2013) · Nature Communications · doi:10.1038/ncomms3612 · Cited by 9,778 · cited 1×
“To further delineate the identity of carcinoma and non-carcinoma cells, we analysed the expression of tumour-associated stromal or immune gene sets proposed in the tumour purity estimation, ESTIMATE 26 .”
Cited by
Items 401–500 of 999
Sun, B., Xun, Z., Zhou, Z., Zhang, N., Piao, M., Li, C., Li, J., Li, S., Zhang, L., Chen, X., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06551-x · Cited by 24
“The signature gene sets of T cells were based on previous studies [26, 27], including naive signature ( CCR7 , LEF1 , SELL , and TCF7 ), regulatory signature ( IL2RA , IL4R , IL7 , TGFB1 , TGFB3 , TGFBI , and TGFBR1 ), costimulatory signature ( CD226 , ICOS , SLAMF1 , TNFRSF14 , TNFRSF25 , and…”
Exploring and analysing single cell multi-omics data with VDJView
Samir, J., Rizzetto, S., Gupta, M., & Luciani, F. (2020) · BMC Medical Genomics · doi:10.1186/s12920-020-0696-z · Cited by 23
Modeling Basins of Attraction for Breast Cancer Using Hopfield Networks
Conforte, A. J., Alves, L. D., Coelho, F. C., Carels, N., & da Silva, F. A. B. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00314 · Cited by 22
“Among them, one received adjuvant trastuzumab treatment and had 75 RNA-Seq samples available, while two patients did not receive any treatment and had 48 and 18 RNA-Seq samples, respectively (Chung et al., 2017).”
BackgroundAizik, L., Dror, Y., Taussig, D. C., Barzel, A., Carmi, Y., & Wine, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.705381 · Cited by 23
Conflicting roles of EGFR expression by subtypes in breast cancer.
Oshi, M., Gandhi, S., Tokumaru, Y., Yan, L., Yamada, A., Matsuyama, R., Ishikawa, T., Endo, I., & Takabe, K. (2021) · Europe PMC (PubMed Central) · Cited by 34
Relationship Between CNVs and Immune Cells Infiltration in Gastric Tumor Microenvironment
Li, F., Wen, H., Bukhari, I., Liu, B., Guo, C., Ren, F., Tang, Y., Mi, Y., & Zheng, P. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.869967 · Cited by 23
“Other genes did not affect the infiltration of immune cells in GC TME (Figures 5B–”
MethodInfluentialA MAP1B–cortactin–Tks5 axis regulates TNBC invasion and tumorigenesis
Inoue, H., Kanda, T., Hayashi, G., Munenaga, R., Yoshida, M., Hasegawa, K., Miyagawa, T., Kurumada, Y., Hasegawa, J., Wada, T., et al. (2023) · The Journal of Cell Biology · doi:10.1083/jcb.202303102 · Cited by 21
Wang, J., Xu, R., Yuan, H., Zhang, Y., & Cheng, S. (2019) · Medicine · doi:10.1097/md.0000000000015872 · Cited by 21
“The trastuzumab-treated patient T1 was excluded by Chung et al([11]) for further transcriptome analysis because their research was focused on classifying nontreated cancer single cells.”
BackgroundMethodInfluentialscRCMF: Identification of Cell Subpopulations and Transition States From Single-Cell Transcriptomes
Zheng, X., Jin, S., Nie, Q. H., & Zou, X. (2019) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2019.2937228 · Cited by 23
“57951 genes across 379 cells related to immune cell lineage, identify seven clusters and 4 transitions (C1-C3,C1-C7,C4-C7 and C6-C7) in primary breast cancer (PBC) [39].”
BackgroundBreathing fresh air into respiratory research with single-cell RNA sequencing
Alexander, M. J., Budinger, G. R. S., & Reyfman, P. A. (2020) · European Respiratory Review · doi:10.1183/16000617.0060-2020 · Cited by 24
Sinha, V. C., Rinkenbaugh, A. L., Xu, M., Zhou, X., Zhang, X., Jeter-Jones, S. L., Shao, J., Qi, Y., Zebala, J. A., Maeda, D. Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25240-z · Cited by 25
Microfluidic design in single-cell sequencing and application to cancer precision medicine
Han, X., Xu, X. J., Yang, C. J., & Liu, G. (2023) · Cell Reports Methods · doi:10.1016/j.crmeth.2023.100591 · Cited by 26
Divide and Conquer—Targeted Therapy for Triple-Negative Breast Cancer
Nedeljković, M., Vuletić, A. M., & Martinović, K. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041396 · Cited by 25
Singh, S., Sutcliffe, M. D., Repich, K., Atkins, K. A., Harvey, J. A., & Janes, K. A. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-1034 · Cited by 19
“Toward a more-direct comparison of 10-cell data with single-cell measurements of gene expression, we extracted 78 KRT8+EPCAM+ carcinoma cells from three cases of luminal breast cancer profiled by scRNA-seq (20) (see Materials and Methods).”
BackgroundMethodResultInfluentialHSP90 inhibition downregulates DNA replication and repair genes via E2F1 repression
Liu, H., Lu, Z., Shi, X., Liu, L., Zhang, P., Golemis, E. A., & Tu, Z. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100996 · Cited by 22
“Differentially expressed genes were analyzed using the gplots package in R language (60, 61).”
MethodThe Role of Innate Immune Cells in Tumor Invasion and Metastasis
Huang, Y., Busuttil, R. A., & Boussioutas, A. (2021) · Cancers · doi:10.3390/cancers13235885 · Cited by 24
PLUS: Predicting cancer metastasis potential based on positive and unlabeled learning
Zhou, J., Lu, X., Chang, W., Wan, C., Lu, X., Zhang, C., & Cao, S. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009956 · Cited by 24
Reverting TP53 Mutation in Breast Cancer Cells: Prime Editing Workflow and Technical Considerations
Abuhamad, A. Y., Zamberi, N. N. M., Ling, S., Naes, S. M., Yusuf, S. N. H. M., Tajudin, A. A., Mohtar, M. A., Syahir, A., & Syafruddin, S. E. (2022) · Cells · doi:10.3390/cells11101612 · Cited by 23
In vitro breast cancer models for studying mechanisms of resistance to endocrine therapy
Cheng, G. J., Leung, E. Y., & Singleton, D. C. (2022) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2022.00084 · Cited by 22
Integrative insights and clinical applications of single-cell sequencing in cancer immunotherapy
Liu, Z., Li, H., Dang, Q., Weng, S., Duo, M., Lv, J., & Han, X. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04608-4 · Cited by 19
“It means that the immune cells with high exhaustion signatures could be targets of immune checkpoint blockade in breast cancer treatment [94].”
BackgroundTang, K., Zhang, J., Cao, H., Xiao, G., Wang, Z., Zhang, X., Zhang, N., Wu, W., Zhang, H., Wang, Q., et al. (2022) · Cancers · doi:10.3390/cancers14225663 · Cited by 24
“Data integration of BRCA (GSE75688 and GSE118389) [34,35] was performed using the R package Seurat (anchoring function).”
MethodProteomics to study cancer immunity and improve treatment
Franciosa, G., Kverneland, A. H., Jensen, A. W. P., Donia, M., & Olsen, J. V. (2023) · Seminars in Immunopathology · doi:10.1007/s00281-022-00980-2 · Cited by 20
Ishwar, D., Premachandran, S., Das, S., Venkatakrishnan, K., & Tan, B. (2024) · Small · doi:10.1002/smll.202406475 · Cited by 23
Single-Cell Imaging of Metastatic Potential of Cancer Cells
Midde, K., Sun, N. N., Rohena, C. C., Joosen, L., Dhillon, H., & Ghosh, P. (2018) · iScience · doi:10.1016/j.isci.2018.11.022 · Cited by 20
Unfolding innate mechanisms in the cancer microenvironment: The emerging role of the mesenchyme
Koliaraki, V., Henriques, A. R., Prados, A., & Kollias, G. A. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20190457 · Cited by 22
GORDON, B. L., & Gadi, V. K. (2020) · Vaccines · doi:10.3390/vaccines8030529 · Cited by 20
“Moreover, using single-cell (sc) RNA-seq to profile CTLs within the breast cancer microenvironment, a large proportion express an exhausted phenotype [26,27].”
MethodNorthstar enables automatic classification of known and novel cell types from tumor samples
Zanini, F., Berghuis, B. A., Jones, R. C., di Robilant, B. N., Nong, R. Y., Norton, J. A., Clarke, M. F., & Quake, S. R. (2020) · Scientific Reports · doi:10.1038/s41598-020-71805-1 · Cited by 16
Cancer Immunotherapy and the Nectin Family
Johnston, R. J., Lee, P. S., Strop, P., & Smyth, M. J. (2020) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-060920-084910 · Cited by 21
Roychowdhury, A., Jondhale, M., Saldanha, E., Ghosh, D., Panda, C. K., Chandrani, P., & Mukherjee, N. (2021) · Gene · doi:10.1016/j.gene.2021.145728 · Cited by 22
Sun, C., Wang, S., Zhang, Y., Yang, F., Zeng, T., Meng, F., Yang, M., Yang, Y., Hua, Y., Fu, Z., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.628677 · Cited by 22
“The cell type annotation was conducted according to the previous report (16).”
MethodParker, K. A., Gooding, A. J., Valadkhan, S., & Schiemann, W. P. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0137 · Cited by 21
Pang, L., Xiang, F., Yang, H. M., Shen, X., Fang, M., Li, R., Long, Y., Li, J., Yu, Y., & Pang, B. (2024) · Scientific Data · doi:10.1038/s41597-024-03127-0 · Cited by 26
“…by identifying gene modules across cancer types 48,49 or dissect the heterogeneity of cancer cells using few samples with small number of cells 50 , we focused on the breast cancer cells and took advantage of the batch correction method to remove batch effect from individual variation for…”
MethodLong non‐coding RNAs: Emerging roles in periodontitis
Xu, J., Yin, Y., Lin, Y., Tian, M., Liu, T., Li, X., & Chen, S. (2021) · Journal of Periodontal Research · doi:10.1111/jre.12910 · Cited by 35
Shu, Z., Long, Q., Zhang, L., Yu, Z., & Wu, X. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c01305 · Cited by 20
An introduction to representation learning for single-cell data analysis
Gunawan, I., Vafaee, F., Meijering, E. H. W., & Lock, J. G. (2023) · Cell Reports Methods · doi:10.1016/j.crmeth.2023.100547 · Cited by 29
Multi-scale characterisation of homologous recombination deficiency in breast cancer
Jacobson, D. H., Shi, P., Fisher, J., & Secrier, M. (2023) · Genome Medicine · doi:10.1186/s13073-023-01239-7 · Cited by 18
“These datasets were used to assess the clinical relevance of our transcriptional signature of HRD. Bulk and single-cell RNA-seq data of 515 cells from 13 samples obtained from Chung et al. was collected from GEO database through the accession number GSE75688 [47].”
MethodZhang, W., Zhang, X., Teng, F., Yang, Q., Wang, J., Sun, B., Liu, J., Zhang, J., Sun, X., Zhao, H., et al. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2024.101239 · Cited by 25
Defining and targeting macrophage heterogeneity in the mammary gland and breast cancer
Elfstrum, A. K., Bapat, A. S., & Schwertfeger, K. L. (2024) · Cancer Medicine · doi:10.1002/cam4.7053 · Cited by 22
Qiu, J., Ren, T., Liu, Q., Jiang, Q., Wu, T., Cheng, L. C., Yan, W., Qu, X., Han, X., & Hua, K. (2024) · Advanced Science · doi:10.1002/advs.202309755 · Cited by 28
Cellular plasticity and metastasis in breast cancer: a pre- and post-malignant problem
Smigiel, J. M., Taylor, S. E., Bryson, B. L., Tamagno, I., Polak, K. L., & Jackson, M. W. (2019) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2019.26 · Cited by 20
“With three distinct clinical subtypes, estrogen and progesterone receptor positive (ER+/PR+), human epidermal growth factor receptor 2 positive (HER2+), and triple negative breast cancer (TNBC; negative for ER, PR, HER2 expression), finding the proper treatment options can be difficult[17–19].”
BackgroundInfluentialWen, W. X., Mead, A. J., & Thongjuea, S. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.01.009 · Cited by 20
“cells Human Smart-Seq HiSeq 2500, 100 bp PE CE [84] (Data from [115])”
BackgroundImmune cell landscape in a human decedent receiving a pig liver xenograft
Tao, K., Ling, Y.-W., Zhang, X., Yang, Z.-X., Zhang, H., Yue, S., Yang, Y., Song, W., Wang, D., Liu, Z., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03860-y · Cited by 24
“T cell subtypes were defined based on established functional markers 14–17 (Extended Data Fig.”
Pang, L., Hu, J. R., Li, F., Yuan, H., Yan, M., Liao, G., Xu, L., Pang, B., Ping, Y., Xiao, Y., et al. (2019) · Cancers · doi:10.3390/cancers11122025 · Cited by 21
“Through a single cell processing pipeline (Figure S3), we constructed the single-cell transcriptomes and confidently distinguished 1766 malignant cells from non-malignant cells as previously described [11,12].”
MethodYao, J., Li, S., & Wang, X. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.781848 · Cited by 26
Jin, X., Wang, Q., Luo, F., Pan, J., Lu, T., Zhao, Y., Zhang, X., Xiang, E., Zhou, C., Huang, B., et al. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002573 · Cited by 24
“The full T cell signature gene lists were extracted from the curated gene list reported by Chung et al.([5]) The gene sets for dendritic cells (DCs) were extracted from a study reported by Liu et al.”
BackgroundMethodPeterson, J. R., Cole, J. A., Pfeiffer, J. R., Norris, G. H., Zhang, Y., Lopez-Ramos, D., Pandey, T., Biancalana, M., Esslinger, H. R., Antony, A. K., et al. (2023) · Breast Cancer Research · doi:10.1186/s13058-023-01654-z · Cited by 19
Ning, L., Quan, C., Wang, Y., Wu, Z., Yuan, P., & Xie, N. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1348299 · Cited by 21
Breast Cancer Immune Landscape: Interplay Between Systemic and Local Immunity
Gerashchenko, T. S., Frolova, A. A., Patysheva, M. R., Fedorov, A. A., Stakheyeva, M. N., Denisov, E. V., & Чердынцева, Н. В. (2024) · Advanced Biology · doi:10.1002/adbi.202400140 · Cited by 25
Advances in Microfluidic Single-Cell RNA Sequencing and Spatial Transcriptomics
Sun, Y., Yu, N., Zhang, J., & Yang, B. (2025) · Micromachines · doi:10.3390/mi16040426 · Cited by 22
“…of units were integrated for processing This standardized process reduces the requirements for experimental operations and, therefore, performs robustly and reproducibly in the characterization and data integration of clinical tissues [54] or blood samples [55]. precious samples [44] (Figure 3c).”
Cell‐cycle dependence of transcriptome gene modules: comparison of regression lines
Vinogradov, A. E., & Anatskaya, O. V. (2020) · FEBS Journal · doi:10.1111/febs.15257 · Cited by 18
Guan, X., Li, J., Cai, J., Huang, S., Liu, H., Wang, S., Zhang, X., Sun, Y., Liu, H., Xie, G., et al. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.130579 · Cited by 19
Grasset, E. M., Deshpande, A. M., Lee, J. W., Cho, Y., Shin, S. M., Coyne, E. M., Hernandez, A., Yuan, X., Zhang, Z., Cimino‐Mathews, A., et al. (2024) · Oncogene · doi:10.1038/s41388-024-03127-9 · Cited by 17
“Single-cell analyses have revealed the extent of tumor microenvironment (TME) cellular diversity [3, 11] but have not addressed how these cells are organized in space.”
Self-citationTumor cell-adipocyte gap junctions activate lipolysis and contribute to breast tumorigenesis
Williams, J., Camarda, R., Malkov, S., Zimmerman, L. J., Manning, S., Aran, D., Beardsley, A. R., de Mark, D. V., Nakagawa, R. M., Chen, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62486-3 · Cited by 21
Zhang, J., Zhang, G., Li, Z., Qu, L., & Wen, C. (2021) · Applied Soft Computing · doi:10.1016/j.asoc.2021.107876 · Cited by 18
Zhang, X. L., Zhang, R., Hou, C., He, R., Wang, Q., Zhou, T.-H., Li, X., Zhai, Q.-L., & Feng, Y.-M. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102082 · Cited by 17
Niu, D., Chen, Y., Mi, H., Mo, Z., & Pang, G. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.974416 · Cited by 19
Saha, T., Detroja, R., Mukherjee, S., & Samson, A. O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012628 · Cited by 17
“Single-cell RNA-sequencing (scRNA-seq) is a useful method to analyze disease heterogeneity at the single-cell level [46].”
MethodComparative Approach to the Temporo-Spatial Organization of the Tumor Microenvironment
Langsten, K. L., Kim, J. H., Sarver, A. L., Dewhirst, M. W., & Modiano, J. F. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01185 · Cited by 20
“Emerging technologies such as single cell sequencing (168, 169) and highly multiplexed 3-dimensional optical imaging (170, 171), individually and combined, will bring about the next transformation in the understanding of the immune landscape of cancer.”
BackgroundInferring Cancer Progression from Single-cell Sequencing while Allowing Mutation LossesPreprint
Ciccolella, S., Gomez, M. S., Patterson, M., Vedova, G. D., Hajirasouliha, I., & Bonizzoni, P. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/268243 · Cited by 17
Sami, A., & Raza, A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1457491 · Cited by 19
Single-Cell Transcriptomic Analysis of Kaposi Sarcoma
Rauch, D. A., Ramos, P. V., Khanfar, M., Harding, J., Joseph, A., Fahad, A., Simonson, P. D., Risch, I., Griffith, O. L., Griffith, M., et al. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1012233 · Cited by 18
Single-cell sequencing and its applications in bladder cancer
Wei, W., Rong, Y., Liu, S., Yang, C., Thokerunga, E., Cui, D., & Wang, F. (2022) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2021.23 · Cited by 18
van der Noord, V. E., van de Water, B., & Dévédec, S. E. L. (2022) · Cancers · doi:10.3390/cancers14184353 · Cited by 19
“These subpopulations also have major differences in oncogenic driver mutations and copy number alterations [10,11,13].”
BackgroundKon, T., Fukuta, K., Chen, Z., Kon‐Nanjo, K., Suzuki, K., Ishikawa, M., Tanaka, H., Burgess, S. M., Noguchi, H., Toyoda, A., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-04351-3 · Cited by 17
Liu, Y., Guo, W., Li, C., Shen, L.-C., Gasser, R. B., Song, J., Chen, D., & Yu, D. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad132 · Cited by 18
Single-cell RNA reveals a tumorigenic microenvironment in the interface zone of human breast tumors
Yang, W. Y., Xu, M., Xu, S., Guan, Q., Geng, S., Wang, J., Wei, W., Xu, H., Liu, Y., Meng, Y., et al. (2023) · Breast Cancer Research · doi:10.1186/s13058-023-01703-7 · Cited by 16
“Given that TME could affect tumor infiltrating immune cells [16, 38], we explored the differences of B cells in three zones.”
BackgroundClinical Implications of Breast Cancer Intrinsic Subtypes
Ríos-Hoyo, A., Shan, N. L., Karn, P. L., & Pusztai, L. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-70875-6_21 · Cited by 23
Zhang, Q., Wang, D., Zhuo, G., Wang, S., Yuan, Y., Wang, L., Ji, L., Wan, Y., Liu, G., & Pan, Y. (2025) · International Journal of Biological Sciences · doi:10.7150/ijbs.98260 · Cited by 19
“Different breast cancer subtypes (Luminal A, Luminal B, Her2+, and TNBC) show unique immune cell types with distinct gene expressions, suggesting dynamic immune interactions with ER, PR and Her2 status between subtypes [5], which can further indicates differential prognosis[6].”
Peng, L., Liu, L., Huang, L., Bai, Z., Chen, M., & Chen, X. (2025) · Applied Soft Computing · doi:10.1016/j.asoc.2025.112839 · Cited by 18
Blood-based analyses of cancer: Circulating myeloid-derived suppressor cells – is a new era coming?
Okła, K., Wertel, I., Wawruszak, A., Bobiński, M. S., & Kotarski, J. (2018) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2018.1477729 · Cited by 20
“scRNA-seq overcame the problems presented by the heterogeneity in gene expression in cells within the same population by enabling the investigation of single cells to determine their phenotype and the significance of their differences [13,68].”
BackgroundInfluentialA Hybrid Clustering Algorithm for Identifying Cell Types from Single-Cell RNA-Seq Data
Zhu, X., Li, H., Xu, Y., Guo, L., Wu, F., Duan, G., & Wang, J. (2019) · Genes · doi:10.3390/genes10020098 · Cited by 17
Servetto, A., Napolitano, F., Angelis, C. D., Placido, P. D., Giuliano, M., Arpino, G., Placido, S. D., Bianco, R., & Formisano, L. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103191 · Cited by 18
“compartments, responsible for intra-tumor heterogeneity, and detect the subclones responsible for adaption to drug exposure and following disease progression [80, 81].”
BackgroundPfisterer, U., Bräunig, J., Brattås, P. L., Heidenblad, M., Karlsson, G., & Fioretos, T. (2021) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22944 · Cited by 18
“strategy to facilitate introduction of single-cell sequencing in a clinical diagnostic setting.(35,37,38,71,73,74,76) However, such approaches provide only indirect genomic information, which is furthermore limited due”
BackgroundscdNet: a computational tool for single-cell differential network analysis
Chiu, Y., Hsiao, T.-H., Wang, L., Chen, Y., & Shao, Y. J. (2018) · BMC Systems Biology · doi:10.1186/s12918-018-0652-0 · Cited by 18
Mouse models in the era of large human tumour sequencing studies
de Ruiter, J. R., Wessels, L. F. A., & Jonkers, J. (2018) · Open Biology · doi:10.1098/rsob.180080 · Cited by 18
“Finally, detailed characterization of non-transformed cells within the tumour—such as cancer-associated fibroblasts and tumour-infiltrating immune cells—can be used to explore the complex interactions between tumour cells and the (immune) microenvironment [155,156] and how these interactions change during tumour progr…”
BackgroundFranzin, R., Stasi, A., Castellano, G., & Gesualdo, L. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1507-2_6 · Cited by 14
Impact of Immune Cell Heterogeneity on HER2+ Breast Cancer Prognosis and Response to Therapy
Perrone, M., Talarico, G., Chiodoni, C., & Sangaletti, S. (2021) · Cancers · doi:10.3390/cancers13246352 · Cited by 22
“The concept that tumor-infiltrating lymphocytes (TILs) are a good prognostic indicator for TNBC and HER2+ BCs is generally accepted and they are now being included in clinical diagnostic practice [22,23].”
MethodInfluentialVinogradov, A. E., & Anatskaya, O. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076196 · Cited by 15
“The datasets were the ‘breast cancer’ GSE75688 [107], ‘melanoma’ GSE72056 [108], and ‘myeloma’ GSE106218 [109].”
Single-Cell RNA-Sequencing: Opening New Horizons for Breast Cancer Research
Xiang, L., Rao, J., Yuan, J., Xie, T., & Yan, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179482 · Cited by 21
“Chung et al. [76] analyzed samples from 11 breast cancer patients using scRNA-seq and identified copy number variations that distinguish cancer cells from normal cells.”
Cancer cell immune mimicry delineates onco-immunologic modulation
Gao, R., He, B., Huang, Q., Wang, Z., Yan, M., Lam, E. W. ‐., Lin, S., Wang, B., & Liu, Q. (2021) · iScience · doi:10.1016/j.isci.2021.103133 · Cited by 18
Simão, D. F., Gomes, C. M., Alves, P. M., & Brito, C. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107883 · Cited by 17
A neural network-based method for exhaustive cell label assignment using single cell RNA-seq data
Li, Z., & Feng, H. (2022) · Scientific Reports · doi:10.1038/s41598-021-04473-4 · Cited by 17
“This technology has been applied in many research areas including evolutionary 1 , immunology 2 , neurodegenerative diseases 3 , and cancer 4,5 .”
MethodEvaluation of single-cell RNAseq labelling algorithms using cancer datasets
Christensen, E., Luo, P., Turinsky, A. L., Husić, M., Mahalanabis, A., Naidas, A., Díaz-Mejía, J. J., Brudno, M., Pugh, T. J., Ramani, A. K., et al. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac561 · Cited by 19
“Four different subtypes comprise this dataset, including cancer cells, stromal cells and immune cells from the tumor microenvironment [35].”
BackgroundO’Leary, K. A., Bates, A. M., Jin, W. J., Burkel, B. M., Sriramaneni, R. N., Emma, S. E., Nystuen, E. J., Sumiec, E. G., Ponik, S. M., Morris, Z. S., et al. (2023) · Breast Cancer Research · doi:10.1186/s13058-023-01671-y · Cited by 18
Tian, C., Zeng, S., & Luo, J. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s255675 · Cited by 15
Gao, Q., Wu, H., Duan, L., Lv, G., & Quan, D. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1648987 · Cited by 20
Zhang, L., Liu, Z., & Zhu, J. (2021) · Medicine · doi:10.1097/md.0000000000025414 · Cited by 14
“In this dataset, 317 tumor cells were prepared from 11 breast tumor samples covering four subtypes of breast cancer.([17]) Six out of the 11 samples were basal-like (TNBC) from 5 patients (BC07, BC07LN, BC08, BC09, BC10, BC11).”
BackgroundLv, L.-H., Lu, J.-R., Zhao, T., Liu, J., & Hai-qi, L. (2022) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-022-09510-0 · Cited by 15
“Previous study demonstrated that both innate and adaptive immune cells in breast cancer showed immunosuppressive gene expression characteristics [21].”
BackgroundChicco, D., Sanavia, T., & Jurman, G. (2023) · BioData Mining · doi:10.1186/s13040-023-00325-1 · Cited by 14
“Genetic signatures can be derived from microarray gene expression [3], RNA-Seq gene expression [4], but also from other regulatory gene expression elements like microRNA, DNA methylation [5] and other biomolecular data.”
BackgroundFaur, F. I., Dobrescu, A., Clim, A., Pașca, P., Prodan-Bărbulescu, C., Gherle, B., Tarţa, C., Isaic, A., Brebu, D. A., Duță, C., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11113037 · Cited by 13
Jacobo, M. J., Donnella, H. J., Sobti, S., Kaushik, S., Goga, A., & Bandyopadhyay, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-53999-w · Cited by 17
Huang, Z., Wang, J., Sun, B., Qi, M., Gao, S., & Liu, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-54888-y · Cited by 17
Recent progress and applications of single-cell sequencing technology in breast cancer
Hawsawi, Y. M., Khoja, B. B., Aljaylani, A. O., Jaha, R., Alderbi, R. M., Alnuman, H., & Khan, M. I. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1417415 · Cited by 17
Advances of single-cell genomics and epigenomics in human disease: where are we now?
Kamies, R., & Martinez‐Jimenez, C. P. (2020) · Mammalian Genome · doi:10.1007/s00335-020-09834-4 · Cited by 22
Savino, A., Marzo, N. D., Provero, P., & Poli, V. (2021) · Cancers · doi:10.3390/cancers13133371 · Cited by 15
“To overcome these limitations, a number of approaches have been introduced: (i) laser capture microdissection (LCM) is commonly employed to separate cell compartments that are histologically well defined [44]; (ii) spatial transcriptomics has allowed for the obtaining of spatially-resolved profiles of stroma-rich and…”
MethodLe, M., Odate, T., Kawai, M., Oishi, N., & Kondo, T. (2022) · Breast Cancer Research and Treatment · doi:10.1007/s10549-022-06768-0 · Cited by 14
“This phenomenon, in turn, can be explained by the clonal evolution of the tumor cells, leading to different morphologies and biological behaviors [14, 15].”
BackgroundA Gene Rank Based Approach for Single Cell Similarity Assessment and Clustering
Xu, Y., Li, H., Pan, Y. F., Luo, F., Wu, F., & Wang, J. (2019) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2019.2931582 · Cited by 14
Zhang, X., & Mak, M. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab053 · Cited by 16
Pan-cancer single cell RNA-seq uncovers recurring programs of cellular heterogeneityPreprint
Kinker, G. S., Greenwald, A., Tal, R., Orlova, Z., Cuoco, M. S., McFarland, J. M., Warren, A. C., Rodman, C., Roth, J. A., Bender, S. A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/807552 · Cited by 14
“Single-cell RNA sequencing (scRNA-seq) has emerged as a valuable tool to study cell-to-cell heterogeneity within tumors (Chung et al., 2017; Filbin et al., 2018; Kim et al., 2016; Lambrechts et al., 2018; Li et al., 2017; Patel et al., 2014; Puram et al., 2017; Tirosh et al., 2016a; Tirosh et al.,…”
MethodInfluentialRuan, X., Tao, M., Dong, Y., Hu, L., Xu, G., Hu, C., Huang, Y., Wang, Y., Yu, J., Luo, W. F., et al. (2025) · Endocrine Related Cancer · doi:10.1530/erc-24-0169 · Cited by 14
Metadata
- Authors
- Chung, W., Eum, H. H., Lee, H.-O., Lee, K.-M., Lee, H.-B., Kim, K.-T., Ryu, H. S., Kim, S., Lee, J. E., Park, Y. H., Kan, Z., Han, W., & Park, W.-Y.
- Affiliations
- Samsung Medical Center (KR)
- Seoul National University (KR)
- Pfizer (United States) (US)
- Corresponding author
- Han, Wonshik
- Park, Woong-Yang
- ORCID
- Venue
- Nature Communications
- Published
- 2017-05-05
- Volume
- 8
- Issue
- 1
- Pages
- 15081-15081
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5424158
- OpenAlex
- W2610509384
- Cited by
- 992
- References
- 62
- Citations by year
- 2026: 57 · 2025: 85 · 2024: 116 · 2023: 117 · 2022: 148 · 2021: 191 · 2020: 106 · 2019: 93 · 2018: 63 · 2017: 11
- FWCI
- 30.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Foundation
- National Research Foundation of Korea (2015R1A2A2A01008264, 2016R1A5A1011974)
- Samsung
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- breast cancer, intratumoral heterogeneity, tumor immune microenvironment, tumor stroma, T cells, B cells, macrophages, regulatory T cells, T cell exhaustion, M2 macrophages, tumor subtypes, tumor transcriptome, copy number variation
- MeSH terms
- Exome Sequencing, B-Lymphocytes, Breast Neoplasms, Female, Humans, Lymph Nodes, Macrophages, Receptors, Estrogen, Receptors, Progesterone, T-Lymphocytes, Lymphocytes, Tumor-Infiltrating, Sequence Analysis, RNA, Carcinoma, Ductal, Breast, Erb-b2 Receptor Tyrosine Kinases, Receptor, ErbB-2, Gene Expression Profiling, DNA Copy Number Variations, Single-Cell Analysis, Tumor Microenvironment, Triple Negative Breast Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.